Ana Martínez‐Feito

Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars

M. Begoña Ruiz-Argüello, A Maguregui, Ainhoa Ruiz del Agua et al. · Annals of the Rheumatic Diseases · 2016 · 76 citations

Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation

Ana Martínez‐Feito, Josefa Melero, Sergio Mora-Díaz et al. · Immunobiology · 2015 · 31 citations

Immunogenetics, Autoimmune Disease, Autoantibody Production +13

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

Cristina Regueiro, Laura Nuño, Ana M. Ortiz et al. · Scientific Reports · 2017 · 21 citations · Full text

Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients

Teresa Jurado‐Guerrero, Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito et al. · The Open Rheumatology Journal · 2017 · 19 citations · Full text

Optimal concentration range of golimumab in patients with axial spondyloarthritis.

Ana Martínez‐Feito, Chamaida Plasencia‐Rodríguez, Victoria Navarro‐Compán et al. · PubMed · 2018 · 18 citations